There are 150 resources available
PET/CT
Presenter: Desiree Deandreis, Italy
Session: Session XI: Minisymposium: The Role of Functional Imaging in GI Cancer
Resources:
Slides
Q&A and Panel Discussion
Presenter: Tanios Bekaii-Saab, United States; Gerald Prager, Austria; Pia Osterlund, Finland
Session: Session XIII: Meet the Experts: Customized Dosing for Kinase Inhibitors
Pancreatic Cancer on the Rise in Young Adults
Presenter: Irit Ben-Aharon, Israel
Session: Session XII: Minisymposium: Special Topics in Young Adults with Cancer
Resources:
Slides
Reinforcing clinical outcomes with patient-reported QoL outcomes in patients with mCRC receiving FTD/TPI: pooled analysis of PRECONNECT and TALLISUR studies
Presenter: Lucjan Wyrwicz, Poland
Session: Session X: Presentation of Selected Colorectal Cancer Abstracts
Resources:
Slides
Radiomics in GI Cancer
Presenter: Joost van Griethuysen, Netherlands
Session: Session XI: Minisymposium: The Role of Functional Imaging in GI Cancer
Resources:
Slides
Biomarker analysis using plasma angiogenesis factors in the TRUSTY study: A randomized phase 2/3 study of trifluridine/tipiracil plus bevacizumab as second-line treatment for metastatic colorectal cancer
Presenter: Hiroya Taniguchi, Japan
Session: Session X: Presentation of Selected Colorectal Cancer Abstracts
Resources:
Slides
Chemotherapy in Pregnancy and Fertility Preservation in Young Adults Treated With Chemotherapy
Presenter: Frédéric Amant, Belgium
Session: Session XII: Minisymposium: Special Topics in Young Adults with Cancer
Resources:
Slides
SO-20: Stanniocalcin 1 (STC1) in patients with refractory colorectal cancer (CRC) treated with regorafenib: An exploratory analysis of the CORRECT trial
Presenter: Christophe Borg, France
Session: Session X: Presentation of Selected Colorectal Cancer Abstracts
Resources:
Slides
Discussant: SO-18, SO-19, SO-20, SO-21
Presenter: Tanios Bekaii-Saab, United States
Session: Session X: Presentation of Selected Colorectal Cancer Abstracts
Resources:
Slides
Optimal maintenance treatment strategy following an anti-EGFR-based first-line induction therapy in patients with RAS wild type metastatic colorectal cancer: an individual patient data pooled analysis of clinical trials
Presenter: Alessandra Raimondi, Italy
Session: Session X: Presentation of Selected Colorectal Cancer Abstracts
Resources:
Slides